IMVT CIK: 1764013

Immunovant, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY26
FY22 – FY26

Assets

(positive)
Change from FY22 to FY26
billions USD
FY22:
0.51
FY23:
0.40
FY24:
0.67
FY25:
0.77
FY26:
0.95
(positive)
Change from FY22 to FY26
billions USD
FY22:
0.00
FY23:
0.00
FY24:
0.00
FY25:
0.01
FY26:
0.01
Total assets
Change from FY22 to FY26
billions USD
FY22:
0.52
FY23:
0.41
FY24:
0.67
FY25:
0.78
FY26:
0.96

Liabilities & Equity

(negative)
Change from FY22 to FY26
billions USD
FY22:
0.04
FY23:
0.04
FY24:
0.05
FY25:
0.07
FY26:
0.10
(negative)
Change from FY22 to FY26
billions USD
FY22:
0.00
FY23:
0.00
FY24:
0
FY25:
0
FY26:
0
(positive)
Change from FY22 to FY26
billions USD
FY22:
0.47
FY23:
0.36
FY24:
0.62
FY25:
0.71
FY26:
0.85
Total liabilities & equity
Change from FY22 to FY26
billions USD
FY22:
0.52
FY23:
0.41
FY24:
0.67
FY25:
0.78
FY26:
0.96

All amounts in billions USD Data source:SEC EDGAR